CHArt: Art Therapy to Address Hospital Clinician Burnout

Sponsor
Barts & The London NHS Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05728086
Collaborator
Queen Mary University of London (Other)
125
2
16.3

Study Details

Study Description

Brief Summary

A structured group art therapy intervention, comprising six 60 - 90-minute weekly workshops.

Condition or Disease Intervention/Treatment Phase
  • Other: Group art therapy
N/A

Detailed Description

The CHArt group art therapy intervention builds on a 6-week art therapy group intervention piloted with Barts Health oncology and palliative care doctors (Tjasink, M. 2019). It incorporates elements of workshops delivered for staff support by Barts art therapists during the Covid-19 pandemic (Tjasink, M., Stevens, P. 2022).

The intervention is broadly informed by affective neuroscience and evolutionary psychology theories with an emphasis on compassion-focused and resource-oriented therapeutic practice. Whilst the intervention draws on diverse influences, it aligns with the principles of Compassion Focussed Therapy (CFT), an integrative, bio-physiological psychological model underpinned by evolutionary theory.

Intervention elements include psycho-education, individual art making, collaborative group art making, art making in pairs, exploring a range of art materials and techniques (including clay, paint, natural objects and non-traditional mark - making materials), art-based grounding exercises and reflective discussion.

The intervention manual was developed by the study's Chief Investigator with input from a group of three art therapy experts (Health and Care Professions Council (HCPC) accredited art therapists working in National Health Service (NHS) medical contexts with experience of delivering art therapy - based staff support) and three experts by experience (Health Care professionals with experience of participating in art therapy - based staff support groups at work). Adherence to the intervention will be monitored through two adherence tools (therapist self reported and independent observer).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
125 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Waitlist randomized controlled trial (RCT) design comprising an intervention group and a waitlist-control groupWaitlist randomized controlled trial (RCT) design comprising an intervention group and a waitlist-control group
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Art Therapy to Address Hospital Clinician Burnout and Psychosocial Distress: a Randomised Controlled Trial
Anticipated Study Start Date :
Feb 20, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group art therapy

Participants randomised to the intervention group receive the group art therapy intervention shortly after baseline assessment. Adherence to the intervention will be checked via an adherence questionnaire completed by therapist delivering the intervention after each session. In addition, 20% of sessions will be observed by an independent researcher for adherence checking.

Other: Group art therapy
The intervention is a manualised programme of group art therapy based on a bio-psychosocial therapeutic model. The programme is made up of six 60 - 90-minute art therapy group sessions facilitated by an experienced HCPC (Health and Care Professions Council) registered Art Therapists trained in the intervention.

No Intervention: waitlist control group

Participants randomised to the waitlist control group will complete outcomes measures at baseline and at the end of a 6 week waiting period. They will then begin the intervention (1-2 weeks after the intervention group has finished).

Outcome Measures

Primary Outcome Measures

  1. Change in burnout element 'Emotional Exhaustion' assessed using the Emotional Exhaustion scale of The Maslach Burnout Inventory - Human Services Survey (MBI-HSS) [Baseline [T1], post 6-week intervention / post 6-week wait [T2], 12 week post intervention follow up [T3]]

    The MBI-HSS assesses three elements of burnout syndrome: emotional exhaustion, depersonalization, and lack of personal accomplishment. Each element is measured by a separate scale. The Emotional Exhaustion (EE) scale assesses feelings of being emotionally over-extended and exhausted at work. It includes 9 items which are scored on a 7-item Likert scale from 0 = never to 6 = every day. The scale has a score range of 0-54 with higher scores corresponding to greater experiences of burnout.

Secondary Outcome Measures

  1. Change in burnout element 'depersonalisation' assessed using the Depersonalisation scale of The Maslach Burnout Inventory - Human Services Survey (MBI-HSS) [Baseline [T1], post 6-week intervention / post 6-week wait [T2], 12 week post intervention follow up [T3]]

    Depersonalisation scale of the MBI - HSS The 5-item Depersonalization (DP) scale assesses an emotionally distant / indifferent response toward patients. It includes 6 items which are scored on a 7-item Likert scale from 0 = never to 6 = every day. The scale has a score range of 0-30 with higher scores corresponding to greater experiences of burnout.

  2. Change in burnout element 'personal accomplishment' assessed using the Personal Accomplishment scale of The Maslach Burnout Inventory - Human Services Survey (MBI-HSS) [Baseline [T1], post 6-week intervention / post 6-week wait [T2], 12 week post intervention follow up [T3]]

    Personal Accomplishment (PA) scale assesses feelings of competence and achievement in work with people. It includes 8 items which are scored on a 7-item Likert scale from 0 = never to 6 = every day. The scale has a score range of 0-48 with lower scores corresponding to greater experiences of burnout.

  3. Change in anxiety assessed using the Generalised Anxiety Disorder Questionnaire (GAD 7) [Baseline [T1], post 6-week intervention / post 6-week wait [T2], 12 week post intervention follow up [T3]]

    The GAD 7 assesses anxiety. It includes 7 items which are scored on a 4-item Likert scale from 0 = not at all to 3 = nearly every day. The scale has a score range of 0-21 with higher scores corresponding to greater levels of anxiety.

  4. Change in depression assessed using the Personal Health Questionnaire Depression Scale (PHQ 8) [Baseline [T1], post 6-week intervention / post 6-week wait [T2], 12 week post intervention follow up [T3]]

    The PHQ 8 assesses severity of depression. It includes 8 items which are scored on a 4-item Likert scale from 0 = not at all to 3 = nearly every day. The scale has a score range of 0-24 with higher scores corresponding to greater severity of depression.

  5. Change in perceived stress assessed using the Perceived Stress Scale (PSS-10) [Baseline [T1], post 6-week intervention / post 6-week wait [T2], 12 week post intervention follow up [T3]]

    The PSS10 assesses perceived stress. It includes 10 items which are scored on a 5-item Likert scale from 0 = never to 4 = very often. The scale has a score range of 0-40 with higher scores corresponding to greater levels of perceived stress.

  6. CHArt Feedback Questionnaire [post 6-week intervention [T2]]

    This is a participant experience feedback questionnaire. It includes 8 items on themes of perceived helpfulness, perceived behavioural change and attribution of change, barriers and enablers to attendance. Questions include multiple choice and follow - up free text elements. For example Question 6: Were there any barriers / challenges to attending? Yes, definitely; Yes, some; Not really; Not at all If so, what were they and how did you address them? If not, what made attendance possible for you?

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • • Healthcare professional employed in a patient facing clinical role by Barts Health NHS Trust or Barts Bank partners

  • 18 years or older

  • Willing and able to provide informed consent

  • Able to attend the group intervention sessions

  • Moderate to severe risk scored on any of the three MBI - HSS subscales or on the

PSS 10:
  • emotional exhaustion score of ≥17, or

  • depersonalization score of ≥7, or

  • personal accomplishment score of ≤ 38 or

  • perceived stress (≥ 14)

Exclusion Criteria:
  • • Unwilling or unable to give consent

  • Diagnosed with or treated for a serious depressive condition, a personality disorder or psychosis in the past 12 months. (Self-reporting through screening.)

  • Attempted suicide or made plans to commit suicide in the past 12 months. (Self-reporting through screening.)

  • Individual does not provide direct patient care for Barts Health NHS Trust

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Barts & The London NHS Trust
  • Queen Mary University of London

Investigators

  • Study Chair: Stefan Priebe, Queen Mary University of London

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Barts & The London NHS Trust
ClinicalTrials.gov Identifier:
NCT05728086
Other Study ID Numbers:
  • 316097
First Posted:
Feb 14, 2023
Last Update Posted:
Feb 14, 2023
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Barts & The London NHS Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 14, 2023